DVA Stock Recent News
DVA LATEST HEADLINES
DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.
DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach.
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close.
In the most recent trading session, DaVita HealthCare (DVA) closed at $151.37, indicating a +0.39% shift from the previous trading day.
DVA's stable core business and global expansion are offset by rising labor costs and declining commercial mix, creating a mixed outlook for investors.
DaVita HealthCare (DVA) reachead $150.78 at the closing of the latest trading day, reflecting a +0.25% change compared to its last close.
The latest trading day saw DaVita HealthCare (DVA) settling at $149.83, representing a +0.31% change from its previous close.
DaVita HealthCare (DVA) closed the most recent trading day at $141.12, moving -1.06% from the previous trading session.
DENVER , March 6, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at the Barclays Global Healthcare Conference 2025 on Tuesday, March 11, 2025, at 9:00 a.m. EDT. To view the live webcast, visit the Barclays page and create a free registration.